Document:

EX-10.1

 Exhibit 10.1 

SUBSCRIPTION AGREEMENT 
 CytoDyn Inc. 

1111 Main Street, Suite 660 
 Vancouver, Washington 

The undersigned (the “Investor”) hereby confirms its agreement with CytoDyn Inc., a Delaware corporation (the
“Company”), as follows: 
 1.    This Subscription Agreement, including the Terms and Conditions
For Purchase of Shares and Warrants attached hereto as Annex I (collectively, (this “Agreement”) is made as of the date set forth below between the Company and the Investor. 

2.    The Company has authorized the issuance and sale to certain investors of (i) shares (each a
“Share,” collectively, the “Shares”) of its common stock, par value $0.001 per share (the “Common Stock”) and (ii) warrants (each, a “Warrant,” and, collectively,
the “Warrants”), each to purchase one share of Common Stock at an exercise price of $0.45 per share, exercisable for a period of five (5) years from its original date of issuance, to be evidenced by a Common Stock Purchase
Warrant in substantially the form attached hereto as Annex III; with such Shares and Warrants to be issued at an aggregate purchase price of $0.40 (the “Purchase Price”) per fixed combination of one Share
and one-half Warrant. The Shares and Warrants are immediately separable and will be issued separately. The shares of Common Stock issuable upon exercise of the Warrants are referred to herein as the
“Warrant Shares” and, together with the Shares and the Warrants, are referred to herein as the “Securities.” 

3.    The offering and sale of the Securities (the “Offering”) are being made pursuant to
(1) an effective Registration Statement on Form S-3, No. 333-223195 (the “Registration Statement”) filed by the Company with the
Securities and Exchange Commission (the “Commission”) and declared effective on March 7, 2018 (including the base prospectus contained therein (the “Base Prospectus”)), (2) if applicable, certain “free
writing prospectuses” (as that term is defined in Rule 405 under the Securities Act of 1933, as amended (the “Securities Act”)), that have been or will be filed (if required) with the Commission and delivered to the
Investor on or prior to the date hereof, containing certain supplemental information regarding the Securities, the terms of the Offering and the Company (the “Issuer Free Writing Prospectus”), and (3) a prospectus supplement
(the “Prospectus Supplement” and together with the Base Prospectus, the “Prospectus”) containing certain supplemental information regarding the Securities and terms of the Offering that has been or will be filed
with the Commission and delivered to the Investor (or made available to the Investor by the filing by the Company of an electronic version thereof with the Commission). 

4.    The Company and the Investor agree that the Investor will purchase from the Company and the Company will
issue and sell to the Investor the Shares and Warrants set forth below for the aggregate purchase price set forth below. The Shares and Warrants shall be purchased pursuant to the Terms and Conditions for Purchase of Shares and Warrants attached
hereto as Annex I and incorporated herein by this reference as if fully set forth herein. 

 5.    The settlement of the Shares purchased by the Investor
shall be effected by crediting the account of the Investor’s prime broker with the Depository Trust Company (“DTC”) through its Deposit/Withdrawal At Custodian (“DWAC”) delivery system, whereby Investor’s prime broker
(as specified by such Investor on Annex II attached hereto) shall initiate a DWAC transaction on the Closing Date using its DTC participant identification number, and released by Computershare, the Company’s transfer
agent (the “Transfer Agent”), at the Company’s direction. NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE INVESTOR AND THE COMPANY, THE INVESTOR SHALL: 

 

	 	(I)	 DIRECT THE BROKER-DEALER AT WHICH THE ACCOUNT OR ACCOUNTS TO BE CREDITED WITH THE SHARES ARE MAINTAINED TO
SET UP A DWAC INSTRUCTING THE TRANSFER AGENT TO CREDIT SUCH ACCOUNT OR ACCOUNTS WITH THE SHARES, AND 

  

	 	(II)	 REMIT BY WIRE TRANSFER THE AMOUNT OF FUNDS EQUAL TO THE AGGREGATE PURCHASE PRICE FOR THE SHARES AND WARRANTS
BEING PURCHASED BY THE INVESTOR TO THE FOLLOWING ACCOUNT: 

  

					
	                                      
                  	  	 [***]
	  	

 IT IS THE INVESTOR’S RESPONSIBILITY TO (A) MAKE THE NECESSARY WIRE TRANSFER IN A TIMELY MANNER
AND (B) ARRANGE FOR SETTLEMENT BY WAY OF DWAC IN A TIMELY MANNER. IF THE INVESTOR DOES NOT DELIVER THE AGGREGATE PURCHASE PRICE FOR THE SHARES AND WARRANTS OR DOES NOT MAKE PROPER ARRANGEMENTS FOR SETTLEMENT IN A TIMELY MANNER,
THE SHARES AND WARRANTS MAY NOT BE DELIVERED AT CLOSING TO THE INVESTOR OR THE INVESTOR MAY BE EXCLUDED FROM THE CLOSING ALTOGETHER. 

6.    The executed Warrants shall be delivered in accordance with the terms thereof. 

7.    The Investor represents that, except as set forth below, (a) it has had no position, office or other
material relationship within the past three years with the Company or persons known to it to be affiliates of the Company, (b) it is not a member of the Financial Industry Regulatory Authority, Inc. (“FINRA”) or an Associated
Person (as such term is defined under the FINRA’s NASD Membership and Registration Rules Section 1011) as of the Closing, and 

  
 2 

 
(c) neither the Investor nor any group of Investors (as identified in a public filing made with the Commission) of which the Investor is a part in connection with the Offering, acquired, or
obtained the right to acquire, 20% or more of the Common Stock (or securities convertible into or exercisable for Common Stock) or the voting power of the Company on a post-transaction basis. Exceptions: 

 

					
		 	  
	 	
			
		 	(If no exceptions, write “none.” If left blank, response will be deemed to be “none.”)	 	

 8.    The Investor represents that it has received (or otherwise had made available
to it by the filing by the Company of an electronic version thereof with the Commission) the Base Prospectus, dated March 7, 2018, which is a part of the Company’s Registration Statement, the documents incorporated by reference therein and
any free writing prospectus (collectively, the “Disclosure Package”), prior to or in connection with the receipt of this Agreement. The Investor acknowledges that, prior to the delivery of this Agreement to the Company,
the Investor will receive certain additional information regarding the Offering, including pricing information (the “Offering Information”). Such information may be provided to the Investor by any means permitted under the
Securities Act, including the Prospectus Supplement, a free writing prospectus and oral communications. 

9.    No offer by the Investor to buy Shares and Warrants will be accepted and no part of the Purchase Price will
be delivered to the Company until the Investor has received the Offering Information and the Company has accepted such offer by countersigning a copy of this Agreement, and any such offer may be withdrawn or revoked, without obligation or commitment
of any kind, at any time prior to the Company sending (orally, in writing or by electronic mail) notice of its acceptance of such offer. An indication of interest will involve no obligation or commitment of any kind until the Investor has been
delivered the Offering Information and this Agreement is accepted and countersigned by or on behalf of the Company. 

10.    The Company acknowledges that the only material, non-public
information relating to the Company or its subsidiaries that the Company, its employees or agents has provided to the Investor in connection with the Offering prior to the date hereof is the existence of the Offering. 

  
 3 

 Number of Shares:
                              

Number of Warrants / Warrants Shares:
                             

Purchase Price Per Combined Share and One-Half of One Warrant:
    $0.40                     

Aggregate Purchase Price:
$                              

Please confirm that the foregoing correctly sets forth the agreement between us by signing in the space provided below for that purpose. 

 

			
	  

	INVESTOR

  

			
	By:	 	  

	Print Name:	 	  

	Title:	 	  

	Address:	 	  

 

			
	  

	Email:	 	  

  

			
	Agreed and Accepted
	
	CYTODYN INC.

  

			
	By:	 	  

	Name:	 	
	Title:	 	

  

			
	Dated as of:	 	  

 ANNEX I 

TERMS AND CONDITIONS FOR PURCHASE OF SHARES AND WARRANTS 

1.    Authorization and Sale of the Shares and Warrants. Subject to the terms and conditions of this
Agreement, the Company has authorized the sale of the Shares and Warrants. 
 2.    Agreement to Sell and Purchase
the Shares and Warrants. 
 2.1    At the Closing (as defined in Section 3.1), the
Company will sell to the Investor, and the Investor will purchase from the Company, upon the terms and conditions set forth herein, the number of Shares and Warrants set forth on the last page of the Agreement to which these Terms and
Conditions for Purchase of Shares and Warrants are attached as Annex I (the “Signature Page”) for the aggregate purchase price therefor set forth on the Signature Page. 

2.2    The Company proposes to enter into substantially this same form of Subscription Agreement with certain other
investors (the “Other Investors”) and expects to complete sales of Shares and Warrants to them. The Investor and the Other Investors are hereinafter sometimes collectively referred to as the
“Investors,” and this Agreement and the Subscription Agreements executed by the Other Investors are hereinafter sometimes collectively referred to as the “Agreements.” 

2.3    The Company confirms that neither it nor any other Person acting on its behalf has provided the Investor or
their agents or counsel with any information that constitutes or could reasonably be expected to constitute material, nonpublic information, except as will be disclosed in the Prospectus and/or in one or more filings pursuant to the Securities
Exchange Act of 1934, as amended (the “Exchange Act”) to be made by the Company with the Commission and incorporated by reference into the Prospectus prior to the consummation of the Offering. The Company understands and confirms
that the Investor will rely on the foregoing representations in effecting transactions in securities of the Company. 

3.    Closings and Delivery of the Shares and Warrants and Funds. 

3.1    Closing. The completion of the purchase and sale of the Shares and Warrants (the
“Closing”) shall occur at a place and time (the “Closing Date”) to be specified by the Company, and of which the Investors will be notified in advance by the Company. At the Closing, (a) the Company
shall cause Computershare, the Company’s transfer agent (the “Transfer Agent”), to deliver to the Investor the number of Shares set forth on the Signature Page registered in the name of the Investor or, if so indicated on
the Investor Questionnaire attached hereto as Annex II, in the name of a nominee designated by the Investor (b) the Company shall cause to be delivered to the Investor one Common Stock Purchase
Warrant, in substantially the form attached hereto as Appendix II, evidencing Warrants to purchase the number of Warrant Shares set forth on the Signature Page and (c) the aggregate purchase price for the Shares and Warrants being
purchased by the Investor will be delivered by or on behalf of the Investor to the Company. 

  
 I-1 

 3.2    Conditions to the Obligations of the Parties. 

(a)    Conditions to the Company’s Obligations. The Company’s obligation to issue and sell the
Shares and Warrants to the Investor shall be subject to: (i) the receipt by the Company of the purchase price for the Shares and Warrants being purchased hereunder as set forth on the Signature Page and (ii) the accuracy of the
representations and warranties made by the Investor and the fulfillment of those undertakings of the Investor to be fulfilled prior to the Closing Date. 

(b)    Conditions to the Investor’s Obligations. The Investor’s obligation to purchase the
Shares and Warrants will be subject to the accuracy of the representations and warranties made by the Company and the fulfillment of those undertakings of the Company to be fulfilled prior to the Closing Date. The Investor’s obligations
are expressly not conditioned on the purchase by any or all of the Other Investors of the Shares and Warrants that they have agreed to purchase from the Company. 

3.3    Settlement Procedures. The settlement of the Shares purchased by the Investor shall be
effected by crediting the account of the Investor’s prime broker (as specified by such Investor on Annex II attached hereto) with the Depository Trust Company (“DTC”) through its Deposit/Withdrawal At
Custodian (“DWAC”) delivery system. 
 (a)    Delivery of Funds. No later than one
(1) business day after the execution of this Agreement by the Investor and the Company, the Investor shall remit by wire transfer the amount of funds equal to the aggregate purchase price for the Shares and
Warrants being purchased by the Investor to the following account designated by the Company: 
  

					
	                                 	 	 [***]
	 	

 (b)    Delivery of Shares. No later than one
(1) business day after the execution of this Agreement by the Investor and the Company, the Investor shall direct the broker-dealer at which the account or accounts to be
credited with the Shares being purchased by such Investor are maintained, which broker/dealer shall be a DTC participant, to set up a DWAC instructing the Transfer Agent to credit such account or accounts with the Shares. Such DWAC instruction shall
indicate the settlement date for the deposit of the Shares, which date shall be provided to the Investor by the Company. Upon the closing of the Offering, the Company shall direct the Transfer Agent to credit the Investor’s account or
accounts with the Shares pursuant to the information contained in the DWAC. 

  
 I-2 

 4.    Representations, Warranties and Covenants of the Investor.

 The Investor acknowledges, represents and warrants to, and agrees with, the Company that: 

4.1    The Investor (a) is knowledgeable, sophisticated and experienced in making, and is qualified to make
decisions with respect to, investments in securities presenting an investment decision like that involved in the purchase of the Shares and Warrants, including investments in securities issued by the Company and investments in comparable
companies, (b) has answered all questions on the Signature Page and the Investor Questionnaire and the answers thereto are true and correct as of the date hereof and will be true and correct as of the Closing Date and (c) in connection
with its decision to purchase the number of Shares and Warrants set forth on the Signature Page, has received and is relying only upon the Disclosure Package and the documents incorporated by reference therein. 

4.2     (a) No action has been or will be taken in any jurisdiction outside the United States by the Company that
would permit an offering of the Shares and Warrants, or possession or distribution of offering materials in connection with the issue of the Securities in any jurisdiction outside the United States where action for that purpose is required, and
(b) if the Investor is outside the United States, it will comply with all applicable laws and regulations in each foreign jurisdiction in which it purchases, offers, sells or delivers Securities or has in its possession or distributes any
offering material, in all cases at its own expense. 
 4.3    The Investor has full right, power, authority and
capacity to enter into this Agreement and to consummate the transactions contemplated hereby and has taken all necessary action to authorize the execution, delivery and performance of this Agreement, and (b) this Agreement constitutes a valid
and binding obligation of the Investor enforceable against the Investor in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting
creditors’ and contracting parties’ rights generally and except as enforceability may be subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law) and except as to
the enforceability of any rights to indemnification or contribution that may be violative of the public policy underlying any law, rule or regulation (including any federal or state securities law, rule or regulation). 

4.4    The Investor understands that nothing in this Agreement, the Prospectus, the Disclosure Package or any other
materials presented to the Investor in connection with the purchase and sale of the Shares and Warrants constitutes legal, tax or investment advice. The Investor has consulted such legal, tax and investment advisors and made such investigation as
it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of Shares and Warrants. The Investor also understands that there is no established public trading market for the Warrants being offered in the Offering,
and that the Company does not expect such a market to develop. In addition, the Company does not intend to apply for listing of the Warrants on any securities exchange. The Investor understands that without an active market, the liquidity of the
Warrants will be limited. 
 4.5    The Investor will maintain the confidentiality of all information acquired as
a result of the transactions contemplated hereby prior to the public disclosure of that information by the Company in accordance with Section 13 of this Annex. 

4.6    Since the time at which the Company first contacted such Investor about the Offering, the Investor has not
disclosed any information regarding the Offering to any third parties (other than its legal, accounting and other advisors) and has not engaged in any purchases or sales of the securities of the Company (including, without limitation, any Short
Sales (as 

  
 I-3 

 
defined herein) involving the Company’s securities). The Investor covenants that it will not engage in any purchases or sales of the securities of the Company (including Short Sales) prior
to the time that the transactions contemplated by this Agreement are publicly disclosed. The Investor agrees that it will not use any of the Securities acquired pursuant to this Agreement to cover any short position in the Common Stock if doing so
would be in violation of applicable securities laws. For purposes hereof, “Short Sales” include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not
against the box, and all types of direct and indirect stock pledges, forward sales contracts, options, puts, calls, short sales, swaps, “put equivalent positions” (as defined in Rule 16a-1(h) under
the Exchange Act) and similar arrangements (including on a total return basis), and sales and other transactions through non-U.S. broker dealers or foreign regulated brokers. 

4.7    The Investor is acquiring the Shares and Warrants (including, upon the exercise of the Warrants, the Warrant
Shares) solely for such Investor’s own account for investment purposes only and not with a view to or intent of resale or distribution thereof, in whole or in part. The Investor has no agreement or arrangement, formal or informal, with any
person to sell or transfer all or any part of the Shares, the Warrants, or the Warrant Shares, and the Investor has no plans to enter into any such agreement or arrangement. The Investor agrees to make due inquiry regarding, and not to sell or
transfer the Shares, the Warrants or the Warrant Shares in violation of, any federal and/or state securities laws applicable to the Investor. 

4.8    The Investor has sufficient knowledge and experience in financial and business matters to be capable of
evaluating the merits and risks of an investment in the Securities and is able to bear the economic risks of such investment. 

4.9    The Investor is unaware of, is in no way relying on, and did not become aware of the Offering through or as
a result of, any form of general solicitation or general advertising including, without limitation, any article, notice, advertisement or other communication published in any newspaper, magazine or similar media or broadcast over television, radio
or the Internet (including, without limitation, internet “blogs,” bulletin boards, discussion groups and social networking sites) in connection with the Offering and sale of the Securities and is not subscribing for the Securities and did
not become aware of the Offering through or as a result of any seminar or meeting to which the Investor was invited by, or any solicitation of a subscription by, a person not previously known to the Investor in connection with investments in
securities generally. 
 4.10    The Investor meets the suitability standards set forth in Part B of the Investor
Questionnaire attached hereto as Annex II. 
 4.11    The Investor has taken no action
that would give rise to any claim by any person for brokerage commissions, finders’ fees or the like relating to this Agreement or the transactions contemplated hereby. 

5.    Survival of Representations, Warranties and Agreements. Notwithstanding any investigation made by any
party to this Agreement, all covenants, agreements, representations and warranties made by the Company and the Investor herein will survive the execution of this Agreement, the delivery to the Investor of the Shares and Warrants being purchased and
the payment therefor. 

  
 I-4 

 6.    Notices. All notices, requests, consents and other
communications hereunder will be in writing, will be mailed (a) if within the domestic United States by first-class registered or certified airmail, or nationally recognized overnight express courier, postage prepaid, or by e-mail or (b) if delivered from outside the United States, by International Federal Express or e-mail, and will be deemed given (i) if delivered by first-class
registered or certified mail domestic, three business days after so mailed, (ii) if delivered by nationally recognized overnight carrier, one business day after so mailed, (iii) if delivered by International Federal Express, two business
days after so mailed and (iv) if delivered by e-mail, upon electronic confirmation of receipt, and will be delivered and addressed as follows: 

(a)    if to the Company, to: 

CytoDyn Inc. 

1111 Main Street, Suite 660 

Vancouver, Washington 98660 

Attention: Michael D. Mulholland, Chief Financial Officer 

Email: [***] 

with a copy (which shall not constitute notice) to: 

Lowenstein Sandler LLP 

1251 Avenue of the Americas 

New York, NY 10020 

Attention: Steven M. Skolnick 

Email: [***] 

(b)    if to the Investor, at its address on the Signature Page hereto, or at such other address or addresses as may have
been furnished to the Company in writing. 
 7.    Changes. This Agreement may not be modified or amended
except pursuant to an instrument in writing signed by the Company and the Investor. 
 8.    Headings. The
headings of the various sections of this Agreement have been inserted for convenience of reference only and will not be deemed to be part of this Agreement. 

9.    Severability. In case any provision contained in this Agreement should be invalid, illegal or
unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein will not in any way be affected or impaired thereby. 

10.    Governing Law. This Agreement will be governed by, and construed in accordance with, the internal
laws of the State of New York, without giving effect to the principles of conflicts of law that would require the application of the laws of any other jurisdiction. 

11.    Counterparts. This Agreement may be executed in two or more counterparts, each of which will
constitute an original, but all of which, when taken together, will constitute but one instrument, and will become effective when one or more counterparts have been signed by each party hereto and delivered to the other parties. The Company and the
Investor acknowledge and 

  
 I-5 

 
agree that the Company shall deliver its counterpart to the Investor along with the Prospectus Supplement (or the filing by the Company of an electronic version thereof with the Commission).

 12.    Confirmation of Sale. The Investor acknowledges and agrees that such Investor’s receipt of
the Company’s signed counterpart to this Agreement, together with the Prospectus Supplement (or the filing by the Company of an electronic version thereof with the Commission), shall constitute written confirmation of the Company’s sale of
Shares and Warrants to such Investor. 
 13.    Publicity. The Company and the Investor agree that the
Company shall, as promptly as practicable following the Closing Date, file a current report on Form 8-K with the Securities and Exchange Commission including, but not limited to, a form of this Agreement and
forms of Warrant as exhibits thereto. 

  
 I-6 

 ANNEX II 

INVESTOR QUESTIONNAIRE 

 ANNEX III 

FORM OF COMMON STOCK PURCHASE WARRANTExhibit 101 Tony Cherbak Consulting Agreement

		

			Exhibit 10.1

		

		

			 

		

		
			CONSULTING AGREEMENT
		

		
			﻿
		

		
			THIS CONSULTING AGREEMENT for consulting services ("Agreement") is made and entered into as of August 12, 2019, by and between Resources Connection LLC,  d/b/a Resources Global Professionals (the “Company”), a limited liability company, and Tony Cherbak (the “Consultant”).
		

		
			﻿
		

		
			IT IS AGREED:
		

		
			﻿
		

		
			1.    Independent Contractor Relationship.  In accordance with the mutual intentions of the Company and the Consultant, this Agreement establishes between them an independent contractor relationship going forward, and all of the terms and conditions of this Agreement shall be interpreted in light of that relationship.  There is no intention to create an employer-employee relationship between the Company and Consultant.  Consultant agrees that he will not claim to be an employee of the Company and he will not seek employee benefits from the Company.          
		

		
			﻿
		

		
			2.    Term.  This Agreement shall commence on August 12, 2019, and shall continue to do so until the close of business on August 11, 2020 (the “Term”); provided, however, that the Consultant shall not be obligated to perform should Consultant become physically or mentally disabled from doing so.  Notwithstanding the foregoing, the Agreement may be terminated at any time by the Company pursuant to paragraphs 13 and 15 of this Agreement. 
		

		
			﻿
		

		
			3.    Amount of Service.  It is understood by the parties that the Company does not have the exclusive right to the Consultant’s services.  It is understood and agreed, however, that the Company may (although it has no obligation) call upon Consultant up to twenty (20) hours per month, for services to be rendered at mutually agreeable times and places and so as not to interfere unreasonably with other consulting or employment of the Consultant.  The Consultant warrants and represents that there is no conflict of interest in the Consultant’s other contracts for services or other employment, if any, with the services to be provided pursuant to this Agreement (which includes but is in no way limited to use of another's confidential and proprietary information) and that the Consultant will ensure that no such conflicts arise during the Term of this Agreement.
		

		
			﻿
		

		
			4.    Type of Service.  The Company will purchase from the Consultant, and the Consultant will sell to the Company, the following personal services: to provide assistance to the Finance Department as requested.    The Company’s Chief Executive Officer and Jennifer Ryu, Interim Chief Financial Officer, are the only people authorized to request the Consultant’s services.
		

		
			﻿
		

		
			5.    Payment.  During the Term of this Agreement, the Company shall pay to the Consultant for his services $300.00 per hour for each hour of work (or portion thereof) the Consultant performs services pursuant to this Agreement.  The payment herein provided shall constitute full payment for the Consultant’s services to the Company during the Term of this Agreement, and the Consultant shall not receive any additional benefits or 
		

		

		

		 

		

			Page 1 of 6

		

 

		
		

		
			       compensation for consulting services, except that the Company will reimburse the Consultant for reasonable and customary expenses incurred with the Company's prior written authorization.  All such costs and expenses shall be itemized by statement and each statement shall be accompanied by substantiating bills or vouchers.  The Consultant shall invoice the Company monthly for the performance of such services and the Company shall pay all non-disputed amounts of such invoices within 30 days of receipt.  Consultant agrees to make all tax payments for which he is obligated under the jurisdiction’s tax laws, and will indemnify Company for any claims related to Consultant’s non-payment of such taxes.
		

		
			﻿
		

		
			6.    Consultant Responsible for its Agents and Employees.  The Consultant shall select and shall have full and complete control of and responsibility for all agents, employees and subcontractors, if any, employed or used by the Consultant and for the conduct of the Consultant’s independent business and none of said agents, employees or subcontractors shall be, or shall be deemed to be, the agent, employee or subcontractor of the Company for any purpose whatsoever, and the Company shall have no duty, liability or responsibility, of any kind, to or for the acts or omissions of Consultant or such agents, employees or subcontractors, or any of them.  Consultant agrees to defend, indemnify and hold the Company harmless from and with respect to any and all claims of any kind based on any intentional misconduct or gross negligence of the Consultant or Consultant’s agents, employees or subcontractors.
		

		
			﻿
		

		
			7.    Responsible for Taxes and Indemnification.  Without limiting any of the foregoing, the Consultant agrees to accept exclusive liability for the payment of tax or contributions for unemployment insurance or old age pensions or annuities or social security payments which are measured by the wages, salaries or other remuneration paid to the Consultant or the employees of the Consultant, if any, and to reimburse and indemnify the Company for such taxes or contributions or penalties which the Company may be compelled to pay.  The Consultant also agrees to comply with all valid administrative regulations respecting the assumption of liability for such taxes and contributions.  The Consultant also understands and agrees it and any of its personnel will not be entitled to participate in the Company's benefits or health and welfare plans or 401(k) investment plans, or any other group benefit of the Company.
		

		
			﻿
		

		
			8.    Means and Methods.  The Consultant agrees to furnish personal services as provided herein as an independent contractor using his own means and methods. 
		

		
			﻿
		

		
			9.    Assignment of Work Product.    
		

		
			﻿
		

		
			a.  The Consultant hereby assigns to the Company, the entire right, title and interest for the entire world in and to all work performed, writing(s), formula(s), design(s), model(s), drawing(s), photograph(s), design invention(s) and other invention(s) made, conceived or reduced to practice or authorized by the Company, either solely or jointly with others, for services performed pursuant to this Agreement or with use of information, materials or facilities of the Company received or used by the Consultant during the period in which the Consultant is retained by the Company or its successor in business, under this Agreement.  The 
		

		

		

		 

		

			Page 2 of 6

		

 

		
		

		
			Consultant shall promptly disclose to the Company all work(s), writing(s), formula(s), design(s), other inventions(s) made, conceived, or reduced to practice or authored by the Consultant in the course of, and related to the performance of this Agreement.
		

		
			﻿
		

		
			b.  The Consultant shall sign, execute and acknowledge or cause to be signed, executed and acknowledged without cost, but at the expense of the Company, any and all documents and to perform such acts as may be necessary, useful or convenient for the purpose of securing for the Company or its nominees, patent, trademark, or copyright protection throughout the world upon all such writing(s), formulas(s), design(s), model(s), drawing(s), photograph(s), design invention(s) and other invention(s), title to which the Company may acquire in accordance with the provisions of this clause.
		

		
			﻿
		

		
			10.    Consultant Work Product Owned by the Company.  All information developed under this Agreement, of whatever type relating to the work performed under this Agreement, shall be the exclusive property of the Company.  All machines, instruments and products purchased, manufactured or assembled by the Consultant pursuant to this Agreement and paid for by the Company shall be the exclusive property of the Company.  Upon termination of this Agreement, the Consultant shall dispose of such items as directed by the Company.
		

		
			﻿
		

		
			11.    Confidentiality.  The Consultant agrees that all data and information about the Company's business, plans, finances, plants, equipment, processes and methods of operation disclosed to, acquired by or developed by the Consultant during performance of the work hereunder is and shall remain the exclusive property of the Company.  Except for such information and data as can be proven by the Consultant to be in or to have entered the public domain through no fault of the Consultant, or to have been in the Consultant’s possession prior to disclosure to the Consultant by the Company and/or the performance of Consultant’s services hereunder, Consultant shall during the Term of the Agreement, and thereafter in perpetuity, maintain as confidential and not disclose to third parties or otherwise use, and will enjoin the Consultant’s employees, agents or subcontractors (as applicable) to abide by such restrictions, unless otherwise authorized, in writing, signed by Company (or its successor).   The Consultant agrees that such data and information shall be used by the Consultant solely for the purpose of performing services for the Company, and not for the benefit of any other person or entity whatsoever.
		

		
			﻿
		

		
			12.    Non-Competition.  Consultant shall not, whether for his own account or for the account of any other individual, partnership, firm, corporation or other business organization, (i) during the Term of this Agreement, divert, or attempt to divert, directly or indirectly, or otherwise interfere in a material fashion with any customers, clients or contractors of the Company, or otherwise interfere with the business relationship of the Company and any person or entity, or (ii) during the Term of this Agreement and for a period of one (1) year from the end date of this Agreement, solicit, employ or otherwise engage as an employee, independent contractor or otherwise, any person who is or was within the past year an employee of the Company, or in any manner induce or attempt to 
		

		

		

		 

		

			Page 3 of 6

		

 

		
		

		
			         induce any employee of the Company to terminate his or her employment with the Company.
		

		
			﻿
		

		
			13.    Termination by Death.  This Agreement shall automatically terminate upon the Consultant’s death.  In such event, the Company shall be obligated to pay the Consultant’s estate or beneficiaries only the accrued but unpaid fees and expenses due as of the date of death.
		

		
			﻿
		

		
			14.    No Assignments by Consultant.  The Consultant shall not assign or transfer any rights under this Agreement without the Company's prior written consent, and any attempt of assignment or transfer without such consent shall be void.  The Company may, however, assign the Agreement.
		

		
			﻿
		

		
			15.    Termination by Notice.  This Agreement is terminable by the Company or the Consultant upon two (2) weeks’ notice for any violation by the Company or the Consultant of any provision of this Agreement, including specifically, but in no way limited to, paragraphs 3, 9, 10,  11, and 12 of this Agreement.  If the Company exercises its right to terminate the Agreement, any obligation it may otherwise have under this Agreement shall cease immediately.  The Company shall only be obligated to pay those fees already paid to the Consultant at the time of termination or those already performed.    The Consultant’s obligation pursuant to paragraphs 6,  7,  9, 10 and 11 of this Agreement shall continue in perpetuity.
		

		
			﻿
		

		
			16.    Governing Law.  This Agreement shall be deemed to have been executed and delivered within the State of California, and the rights and obligations of the parties hereunder shall be construed and enforced in accordance with, and governed by, the laws of the State of California without regard to principles of conflict of laws.
		

		
			﻿
		

		
			17.    Severability.  If any provision of this Agreement or the application thereof is held invalid, the invalidity shall not affect other provisions or applications of the Agreement which can be given effect without the invalid provisions or applications and, to this end, the provisions of this Agreement are declared to be severable.
		

		
			﻿
		

		
			18.    Waiver of Breach.  No waiver of any breach of any term or provision of the Agreement shall be construed to be, or shall be, a waiver of any other breach of this Agreement.  No waiver shall be binding unless in writing and signed by the party waiving the breach.
		

		
			﻿
		

		
			19.    Notice.  Any notice required to be given pursuant to this Agreement shall be deemed to have been sufficiently given either when delivered personally or when delivered by first-class mail addressed to either party.  Notices to the Company shall be effective only when addressed to: 
		

		
			﻿
		

		
			Resources Global Professionals
		

		
			Attn: Kate Duchene
		

		
			17101 Armstrong Avenue
		

		
			Irvine, California 92614
		

		

		

		 

		

			Page 4 of 6

		

 

		
		

		
			(or another designated by proper notice under this Agreement).  
		

		
			﻿
		

		
			Notice to the Consultant shall be effective only when addressed to: 
		

		
			Tony Cherbak
		

		
			31151 Calle Bolero
		

		
			San Juan Capistrano, CA 92675
		

		
			﻿
		

		
			20.    Written Reports.  The Consultant, when directed by the Company, shall provide written reports to the Company with respect to the services rendered hereunder.
		

		
			﻿
		

		
			21.    Compliance with the Law.  The Consultant shall comply with any and all applicable laws and regulations including but not limited to health, safety and security rules and regulations which are in effect or which may become applicable.
		

		
			﻿
		

		
			22.    Mutual Drafters.  Each party has cooperated in the drafting and preparation of this Agreement.  Hence, this Agreement shall not be construed against any party on the basis that the party was the drafter.
		

		
			﻿
		

		
			23.    Advice of Counsel.  In entering this Agreement, the parties represent that they have relied upon the advice of their attorneys, who are attorneys of their own choice, and that the terms of this Agreement have been completely read and explained to them by their attorneys, and that those terms are fully understood and voluntarily accepted by them.
		

		
			﻿
		

		
			24.    Arbitration of Disputes.  Any controversy or claim arising out of, connected with, or relating to this Agreement, its enforcement or interpretation, or because of an alleged breach, default, or misrepresentation in connection with any of its provisions, shall be submitted to final and binding arbitration pursuant to the Federal Arbitration Act (“FAA”) and administered by Judicial Arbitration & Mediation Services, Inc. (“JAMS”), pursuant to its Arbitration Rules and Procedures for Arbitration Disputes (which may be found and reviewed at http://www.jamsadr.com/rules-comprehensive-arbitration/). The FAA will govern the enforceability, applicability, interpretation, and implementation of this provision and all procedural issues connected with conducting the arbitration and enforcing or appealing the arbitration award.  The arbitration will be held before a sole arbitrator, selected by mutual agreement of the parties.  If the parties are unable to agree on an arbitrator, the arbitrator will be selected by striking from a list of arbitrators supplied by JAMS.  Any and all claims and/or defenses that would otherwise be available in a court of law will be fully available to the parties, and the Arbitrator will be required to apply legal principles with the same force and effect as if the dispute were adjudicated in a court of law.  Final resolution of any dispute through arbitration must be consistent with applicable substantive law, and may include any remedy or relief provided by applicable state or federal statutes.  At the conclusion of the arbitration, the Arbitrator will issue a written decision that sets forth the essential findings and conclusions upon which the Arbitrator’s award or decision is based.  Any award or relief granted by the Arbitrator hereunder shall be final and binding on the parties hereto, and may be enforced by any court of competent jurisdiction.  Except where the Company is required by law to pay any costs unique to arbitration (e.g., arbitrator’s fees and room fees), such cost/fee(s) will be apportioned between the parties in accordance with applicable law, and 
		

		 

		

			Page 5 of 6

		

 

		any disputes in that regard will be resolved by the Arbitrator.  A party may apply to a court of competent jurisdiction for temporary or preliminary injunctive relief in connection with an arbitrable controversy, but only upon the ground that the award to which that party may be entitled may be rendered ineffectual without such provisional relief.
		

		
			﻿
		

		
			25.    Entire Agreement.  This instrument constitutes and contains the entire Agreement and final understanding between the parties covering the services provided by the Consultant.   It is intended by the parties as a complete and exclusive statement of the terms of their agreement.  It supersedes all prior negotiations and agreements, proposed or otherwise, whether written or oral, between the parties concerning consulting services provided by the Consultant.  Any representation, promise or agreement not specifically included in this Agreement shall not be binding upon or enforceable against either party.  This is fully integrated document.  This Agreement may be modified only with a written instrument duly executed by each of the parties.  No person has any authority to make any representation or promise on behalf of any of the parties not set forth herein and this Agreement has not been executed in reliance upon any representations or promises except those contained herein.
		

		
			﻿
		

		
			26.    Headings not Controlling.  Headings are used only for ease of reference and are not controlling.
		

		
			﻿
		

			
					
						﻿

					
					
						 

					
					
						 

				
	
					
						DATED:  August 12, 2019

					
					
						 

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						/s/ Lauren A. Elkerson

				
	
					
						﻿

					
					
						 

					
					
						Resources Global Professionals

				
	
					
						﻿

					
					
						 

					
					
						By: Lauren A. Elkerson

				
	
					
						﻿

					
					
						 

					
					
						Associate General Counsel - Employment

				

		
			﻿
		

			
					
						﻿

					
					
						 

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						 

				
	
					
						DATED: August 12, 2019

					
					
						 

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						/s/ Tony Cherbak

				
	
					
						﻿

					
					
						 

					
					
						Tony Cherbak

				
	
					
						﻿

					
					
						 

					
					
						 

				
	
					
						﻿

					
					
						 

					
					
						 

				

		
			﻿
		

		 

		

			Page 6 of 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}]]